articleThe LancetJul 1, 2008Closed access

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

CHClive HolmesDBDelphine BocheDWDavid WilkinsonGYGhasem YadegarfarVHVivienne Hopkins

Moorgreen Hospital · University of Southampton · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,389
total citations
FWCI
81.21
Percentile
100%
References
34
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Medicine
  • Placebo
  • Hazard ratio
  • Internal medicine
  • Clinical trial
  • Alzheimer's disease
  • Dementia
  • Disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding